Neuralink expands PRIME trial enrollment to eight participants
入组数8 例最长使用12+ 个月
Summary
Neuralink disclosed expanded enrollment in its PRIME early feasibility study, with early participants sustaining over a year of stable device operation.
Why it matters
入组数是这条产品线目前最直接的产业信号，扩大意味着安全性数据积累到了一定阶段。